Overview

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.
Phase:
Phase 3
Details
Lead Sponsor:
Dow Pharmaceutical Sciences
Treatments:
Benzoyl Peroxide
Clindamycin
Clindamycin palmitate
Clindamycin phosphate